Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01740310 · ClinicalTrials.gov registry record · NA

Vaccine Acceptance in Pregnant Minority Women

A NA study of Pregnancy, sponsored by Emory University.

Completed
Registry status
NA
Development phase
121
Enrollment target
4
Study locations

NCT01740310 is a NA study of Pregnancy that has completed, run by Emory University. The registered enrollment target is 121 participants, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (86% lower). The trial reports 4 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01740310, a NA study of Pregnancy, has completed, sponsored by Emory University.

COMPLETED
Registry status
NA
Development phase
121 participants
Enrollment target
4
Study locations

Study Summary

The purpose of study will be to test two vaccine education strategies to learn how they impact flu and pertussis (Tdap) vaccination rates and attitudes regarding vaccination during pregnancy after participating in the intervention. The education strategies will be based on the elaboration likelihood model (ELM). This model is based on experimental psychology and has been previously used to increase breast cancer screening rates. These education strategies will be delivered through routine prenatal care visits to black/African-American women in Atlanta.

Conditions Studied

Interventions

  • BEHAVIORAL Maternal Vaccine Education

Study Locations (4)

Georgia

  • Grady Health System - Atlanta
  • Emory University Hospital Midtown - Atlanta
  • Dourron OB/Gyn Associates Clinic - Decatur
  • New Millenium Obstetrics & Gynecology - Riverdale

Trial Details

FieldValue
Enrollment Target 121 participants
Start Date 2012-07
Est. Completion 2014-07
Phase NA

Sponsor

Emory University

1,208 total trials

What the Registry Record Tells You About NCT01740310

The ClinicalTrials.gov registry entry for NCT01740310 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 121 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (86% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which Maternal Vaccine Education is the first listed.

NCT01740310 reports 4 study locations spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT01740310 about?

NCT01740310 is a clinical study titled "Vaccine Acceptance in Pregnant Minority Women". The purpose of study will be to test two vaccine education strategies to learn how they impact flu and pertussis (Tdap) vaccination rates and attitudes regarding vaccination during pregnancy after participating in the intervention. The education strategies will be based on the elaboration likelihood...

What is the current status of trial NCT01740310?

This trial is currently completed. It is a NA study. The enrollment target is 121 participants. The study started on 2012-07. Estimated completion is 2014-07.

What conditions does trial NCT01740310 study?

This clinical trial studies the following conditions: Pregnancy.

What interventions are being tested in trial NCT01740310?

The interventions under investigation include: Maternal Vaccine Education (BEHAVIORAL).

Who is sponsoring clinical trial NCT01740310?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01740310 being conducted?

This trial has 4 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pregnancy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.